WHEN they started working on it, their vision was to create a positive impact on the world. For education start-up Gradeup, its young founders — Shobhit Bhatnagar, Vibhu Bhushan and Sanjeev Kumar — saw ‘education as the most fundamental way of empowering people’. “With the rise of mobile phones and ... Read More »

Shares of Bristol-Myers Squibb were hit hard in pre-market trading Friday after news that its blockbuster cancer drug failed a key clinical trial. The drug, called Opdivo, is one of a new set of drugs called immunotherapy. The drug targets the programmed cell death 1 (or PD-1) receptor to essentially ... Read More »